- Filed
- May 17, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 15, 2024 | 349.49M sh |
| Shares Diluted | Q1 2024 · Jan 31, 2024 | 332.49M sh |
| Shares Diluted restated | Q1 2024 · Jan 31, 2023 | 12.83M sh |
| Operating Cash Flow | Q1 2024 · Jan 31, 2024 | −$1.05M |
| Operating Cash Flow restated | Q1 2024 · Jan 31, 2023 | −$662K |
| Long Term Debt | Q1 2024 · Jan 31, 2024 | $2.25M |
| Short Term Debt | Q1 2024 · Jan 31, 2024 | $450K |
| Stockholders Equity | Q1 2024 · Jan 31, 2024 | −$31.79M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2023 | $31.79M |
| Stockholders Equity | Q1 2024 · Oct 31, 2023 | −$546.19K |
| Current Liabilities | Q1 2024 · Jan 31, 2024 | $39.07M |
| Current Liabilities | Q1 2024 · Oct 31, 2023 | $6.28M |
| Total Liabilities | Q1 2024 · Jan 31, 2024 | $41.99M |
| Total Liabilities | Q1 2024 · Oct 31, 2023 | $10.55M |
| Total Liabilities | Q1 2024 · Oct 1, 2022 | $3.15M |
| Current Assets | Q1 2024 · Jan 31, 2024 | $1.53M |
| Current Assets | Q1 2024 · Oct 31, 2023 | $653.86K |
| Total Assets | Q1 2024 · Jan 31, 2024 | $10.55M |
| Total Assets | Q1 2024 · Oct 31, 2023 | $10M |
| Eps Diluted | Q1 2024 · Jan 31, 2024 | −$0.10 |
| Eps Diluted | Q1 2024 · Jan 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Jan 31, 2024 | −$0.10 |
| Eps Basic | Q1 2024 · Jan 31, 2023 | $0.00 |
| Net Income | Q1 2024 · Jan 31, 2024 | −$33.86M |
| Net Income restated | Q1 2024 · Jan 31, 2023 | −$28.78K |
| Operating Income | Q1 2024 · Jan 31, 2024 | −$4.08M |
| Operating Income restated | Q1 2024 · Jan 31, 2023 | −$17.72K |
| Gross Profit | Q1 2024 · Jan 31, 2024 | $369.84K |
| Gross Profit | Q1 2024 · Jan 31, 2023 | $579.05K |
| Cost Of Revenue | Q1 2024 · Jan 31, 2024 | $1.48M |
| Cost Of Revenue | Q1 2024 · Jan 31, 2023 | $445.03K |